Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Image Gallery: Palmar vascular lesions, a tool for diagnosis and prognosis in Fabry disease.

Fredeau L, Karaa S, London J, Matignon MB, Blah N, Montagner C, Lidove O, Mauhin W.

Br J Dermatol. 2019 Dec 25. doi: 10.1111/bjd.18786. [Epub ahead of print] No abstract available.

PMID:
31875942
2.

Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire.

Noël E, Dussol B, Lacombe D, Bedreddine N, Fouilhoux A, Ronco P, Genevaz D, Bekri S, Hagège A, Dupuis-Siméon F, Derrien Ansquer V, Germain DP, Lidove O.

Orphanet J Rare Dis. 2019 Dec 4;14(1):284. doi: 10.1186/s13023-019-1254-7.

3.

Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.

Martis N, Levraut M, Humbert O, Lidove O.

Rheumatology (Oxford). 2019 Dec 1;58(12):2344-2345. doi: 10.1093/rheumatology/kez425. No abstract available.

PMID:
31608941
4.

Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: A Multicenter Study.

Michaud M, Lidove O, Bienvenu B, Chiche L, Urbanski G; TOCIMAI Investigators Group.

Joint Bone Spine. 2019 Sep 12. pii: S1297-319X(19)30124-1. doi: 10.1016/j.jbspin.2019.08.002. [Epub ahead of print] No abstract available.

PMID:
31521792
5.

[Diagnostic journey of type 1 Gaucher Disease patients: A survey including internists and hematologists].

Deriaz S, Serratrice C, Lidove O, Noël E, Masseau A, Lorcerie B, Jaussaud R, Marie I, Lavigne C, Cabane J, Kaminsky P, Chérin P, Maillot F; pour le groupe de travail 'médecine interne-maladies rares'.

Rev Med Interne. 2019 Dec;40(12):778-784. doi: 10.1016/j.revmed.2019.07.011. Epub 2019 Sep 6. French.

PMID:
31500934
6.

[Glassy cell carcinoma of the uterine cervix: An aggressive type of cancer].

Montagner C, Bricou A, Selle F, Kafé H, Mauhin W, Fredeau L, Duval-Chopard L, Slama J, Durand P, Beal C, London J, Lidove O.

Rev Med Interne. 2019 Nov;40(11):754-757. doi: 10.1016/j.revmed.2019.07.014. Epub 2019 Aug 17. French.

PMID:
31431320
7.

[Anorectal manifestations in systemic diseases].

Egal A, London J, Lidove O, Atienza P, Etienney I.

Rev Med Interne. 2019 Nov;40(11):729-732. doi: 10.1016/j.revmed.2019.07.009. Epub 2019 Aug 7. French.

PMID:
31400822
8.

Strong increase of leukocyte apha-galactosidase A activity in two male patients with Fabry disease following oral chaperone therapy.

Lamari F, Mauhin W, Koraichi F, Khrouf W, Bordet C, London J, Lidove O, Charron P.

Mol Genet Genomic Med. 2019 Sep;7(9):e894. doi: 10.1002/mgg3.894. Epub 2019 Aug 8.

9.

Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis.

Martis N, Viau P, Zenone T, Andry F, Grados A, Ebbo M, Castela E, Brihaye B, Denis E, Liguori S, Audemard A, Schoindre Y, Morin AS, Terrier B, Marcq L, Mounier N, Lidove O, Chaborel JP, Quinsat D.

Eur Radiol. 2019 Dec;29(12):6708-6716. doi: 10.1007/s00330-019-06302-9. Epub 2019 Jun 27.

PMID:
31250167
10.

Semen and male genital tract characteristics of patients with Fabry disease: the FERTIFABRY multicentre observational study.

Papaxanthos-Roche A, Maillard A, Chansel-Debordeaux L, Albert M, Patrat C, Lidove O, Germain DP, Perez P, Lacombe D.

Basic Clin Androl. 2019 May 15;29:7. doi: 10.1186/s12610-019-0088-4. eCollection 2019.

11.

Acid sphingomyelinase deficiency (Niemann‒Pick disease Type B) as an inflammatory disease.

Lidove O, Mauhin W, London J.

J Heart Lung Transplant. 2019 May;38(5):583-584. doi: 10.1016/j.healun.2019.02.008. Epub 2019 Feb 16. No abstract available.

PMID:
30846233
12.

Hypermobile Ehlers-Danlos-like syndrome in Fabry disease.

Barbey F, Lidove O, Dormond O.

Clin Genet. 2019 May;95(5):627-628. doi: 10.1111/cge.13497. Epub 2019 Jan 15. No abstract available.

PMID:
30644091
13.

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease.

Mauhin W, Lidove O, Benveniste O.

Orphanet J Rare Dis. 2019 Jan 7;14(1):4. doi: 10.1186/s13023-018-0979-z.

14.

Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).

Wasserstein M, Dionisi-Vici C, Giugliani R, Hwu WL, Lidove O, Lukacs Z, Mengel E, Mistry PK, Schuchman EH, McGovern M.

Mol Genet Metab. 2019 Feb;126(2):98-105. doi: 10.1016/j.ymgme.2018.11.014. Epub 2018 Nov 29. Review.

15.

Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.

Mauhin W, Lidove O, Amelin D, Lamari F, Caillaud C, Mingozzi F, Dzangué-Tchoupou G, Arouche-Delaperche L, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Froissart R, Lacombe D, Ziza JM, Hachulla E, Benveniste O.

Orphanet J Rare Dis. 2018 Jul 31;13(1):127. doi: 10.1186/s13023-018-0877-4.

16.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, Karras A, Khouatra C, Aumaître O, Cohen P, Decaux O, Desmurs-Clavel H, Maurier F, Gobert P, Quémeneur T, Blanchard-Delaunay C, Bonnotte B, Carron PL, Daugas E, Ducret M, Godmer P, Hamidou M, Lidove O, Limal N, Puéchal X, Mouthon L, Ravaud P, Guillevin L; French Vasculitis Study Group.

Ann Rheum Dis. 2018 Aug;77(8):1150-1156. doi: 10.1136/annrheumdis-2017-212768. Epub 2018 May 3.

PMID:
29724729
17.

Non-infective endocarditis: Expanding the phenotype of giant cell arteritis.

Terré A, Lidove O, Georges O, Mesnildrey P, Chennebault H, Ziza JM.

Joint Bone Spine. 2019 Jan;86(1):115-116. doi: 10.1016/j.jbspin.2018.04.002. Epub 2018 Apr 27. No abstract available.

PMID:
29709695
18.

Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.

McGovern MM, Dionisi-Vici C, Giugliani R, Hwu P, Lidove O, Lukacs Z, Eugen Mengel K, Mistry PK, Schuchman EH, Wasserstein MP.

Genet Med. 2017 Sep;19(9):967-974. doi: 10.1038/gim.2017.7. Epub 2017 Apr 13. Review.

19.

Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).

McGovern MM, Avetisyan R, Sanson BJ, Lidove O.

Orphanet J Rare Dis. 2017 Feb 23;12(1):41. doi: 10.1186/s13023-017-0572-x. Review.

20.

Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects.

Serratrice C, Bensalah N, Penaranda G, Bardin N, Belmatoug N, Masseau A, Rose C, Lidove O, Camou F, Maillot F, Leguy V, Magy-Bertrand N, Marie I, Cherin P, Bengherbia M, Carballo S, Boucraut J, Serratrice J, Berger M, Verrot D.

Joint Bone Spine. 2018 Jan;85(1):71-77. doi: 10.1016/j.jbspin.2016.12.002. Epub 2016 Dec 26.

PMID:
28034821
21.

[Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].

Lidove O, Belmatoug N, Froissart R, Lavigne C, Durieu I, Mazodier K, Serratrice C, Douillard C, Goizet C, Cathebras P, Besson G, Amoura Z, Tazi A, Gatfossé M, Rivière S, Sené T, Vanier MT, Ziza JM.

Rev Med Interne. 2017 May;38(5):291-299. doi: 10.1016/j.revmed.2016.10.387. Epub 2016 Nov 22. French.

PMID:
27884455
22.

Cardiac device implantation in Fabry disease: A retrospective monocentric study.

Sené T, Lidove O, Sebbah J, Darondel JM, Picard H, Aaron L, Fain O, Zenone T, Joly D, Charron P, Ziza JM.

Medicine (Baltimore). 2016 Oct;95(40):e4996.

23.

[Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].

Chazal T, Khanine V, Lidove O, Godot S, Ziza JM.

Rev Med Interne. 2017 Jun;38(6):412-415. doi: 10.1016/j.revmed.2016.08.020. Epub 2016 Sep 19. French.

PMID:
27659744
24.

[Combined heart and kidney transplantation in Fabry's disease: Long-term outcomes in two patients].

Tran Ba SN, Lidove O, Dorent R, Debauchez M, Nataf P, Delahousse M, Karras A, Azeroual L, De Lentdecker P, Chauveheid MP, Sené T, Ziza JM.

Rev Med Interne. 2017 Feb;38(2):137-142. doi: 10.1016/j.revmed.2016.03.008. Epub 2016 May 27. French.

PMID:
27241078
25.

Fabry in the older patient: Clinical consequences and possibilities for treatment.

Lidove O, Barbey F, Niu DM, Brand E, Nicholls K, Bizjajeva S, Hughes DA.

Mol Genet Metab. 2016 Aug;118(4):319-25. doi: 10.1016/j.ymgme.2016.05.009. Epub 2016 May 14.

26.

[Treatment of Fabry disease: Successes, failures, and expectations].

Lidove O, Barbey F, Joly D.

Nephrol Ther. 2016 Apr;12 Suppl 1:S105-13. doi: 10.1016/j.nephro.2016.02.003. Epub 2016 Mar 8. Review. French.

PMID:
26968478
27.

Amoxicillin Crystalluria, an Emerging Complication with an Old and Well-Known Antibiotic.

Zeller V, Puyraimond-Zemmour D, Sené T, Lidove O, Meyssonnier V, Ziza JM.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3248. doi: 10.1128/AAC.00359-16. Print 2016 May. No abstract available.

28.

Musculoskeletal manifestations of Fabry disease: A retrospective study.

Lidove O, Zeller V, Chicheportiche V, Meyssonnier V, Sené T, Godot S, Ziza JM.

Joint Bone Spine. 2016 Jul;83(4):421-6. doi: 10.1016/j.jbspin.2015.11.001. Epub 2015 Dec 14.

PMID:
26697993
29.

Posterior reversible encephalopathy syndrome (PRES) in a patient taking adalimumab for spondyloarthritis.

Mahévas T, Lidove O, Yahia SA, Hayet S, Xerri-Campano B, Ziza JM.

Joint Bone Spine. 2016 Mar;83(2):243-4. doi: 10.1016/j.jbspin.2015.08.002. Epub 2015 Oct 21. No abstract available.

PMID:
26475377
30.

Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.

Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D; French Behçet Network.

J Autoimmun. 2015 Aug;62:67-74. doi: 10.1016/j.jaut.2015.06.005. Epub 2015 Jul 8.

PMID:
26162757
31.

Thick heel pads.

Lafay M, Lidove O, Chanson P, Ziza JM.

Joint Bone Spine. 2015 Dec;82(6):463. doi: 10.1016/j.jbspin.2015.04.006. Epub 2015 May 27. No abstract available.

PMID:
26025602
32.

Prevalence of Raynaud phenomenon and nailfold capillaroscopic abnormalities in Fabry disease: a cross-sectional study.

Deshayes S, Auboire L, Jaussaud R, Lidove O, Parienti JJ, Triclin N, Imbert B, Bienvenu B, Aouba A.

Medicine (Baltimore). 2015 May;94(20):e780. doi: 10.1097/MD.0000000000000780.

33.

Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1.

Stirnemann J, Rose C, Serratrice C, Dalbies F, Lidove O, Masseau A, Pers YM, Baron C, Belmatoug N.

Orphanet J Rare Dis. 2015 May 13;10:62. doi: 10.1186/s13023-015-0275-0.

34.

Fabry disease in a geriatric population.

Barbey F, Joly D, Noel E, Drouineau O, Krayenbühl PA, Lidove O.

Clin Genet. 2015 Nov;88(5):499-501. doi: 10.1111/cge.12585. Epub 2015 Apr 10. No abstract available.

PMID:
25865499
35.

Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.

Pagnoux C, Quéméneur T, Ninet J, Diot E, Kyndt X, de Wazières B, Reny JL, Puéchal X, le Berruyer PY, Lidove O, Vanhille P, Godmer P, Fain O, Blockmans D, Bienvenu B, Rollot F, Aït el Ghaz-Poignant S, Mahr A, Cohen P, Mouthon L, Perrodeau E, Ravaud P, Guillevin L; French Vasculitis Study Group.

Arthritis Rheumatol. 2015 Apr;67(4):1117-27. doi: 10.1002/art.39011.

36.

Innate and Adaptive Immune Response in Fabry Disease.

Mauhin W, Lidove O, Masat E, Mingozzi F, Mariampillai K, Ziza JM, Benveniste O.

JIMD Rep. 2015;22:1-10. doi: 10.1007/8904_2014_371. Epub 2015 Feb 18.

37.

[Acid sphingomyelinase deficiency and spleen trauma: splenectomy or not splenectomy?].

Lidove O, Le Fèvre L, Goasguen N, Jamali M, Vercellino L, Garnier M, Khellaf M, Belmatoug N, Ziza JM.

Rev Med Interne. 2015 Sep;36(9):619-22. doi: 10.1016/j.revmed.2014.10.367. Epub 2014 Nov 5. French.

PMID:
25479761
38.

[Current therapeutic strategies in lysosomal disorders].

Kaminsky P, Lidove O.

Presse Med. 2014 Nov;43(11):1174-84. doi: 10.1016/j.lpm.2013.12.022. Epub 2014 May 23. Review. French.

PMID:
24863660
39.

Cirrhosis and liver failure: expanding phenotype of Acid sphingomyelinase-deficient niemann-pick disease in adulthood.

Lidove O, Sedel F, Charlotte F, Froissart R, Vanier MT.

JIMD Rep. 2015;15:117-21. doi: 10.1007/8904_2014_306. Epub 2014 Apr 10.

40.

[Your images. Ehlers-Danlos hyperlax].

Laur C, Lidove O, Meyssonnier V.

Rev Prat. 2013 Oct;63(8):1048. French. No abstract available.

PMID:
24298818
41.

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Legrand F, Renneville A, MacIntyre E, Mastrilli S, Ackermann F, Cayuela JM, Rousselot P, Schmidt-Tanguy A, Fain O, Michel M, de Jaureguiberry JP, Hatron PY, Cony-Makhoul P, Lefranc D, Sène D, Cottin V, Hamidou M, Lidove O, Baruchel A, Dubucquoi S, Bletry O, Preudhomme C, Capron M, Prin L, Kahn JE; French Eosinophil Network.

Medicine (Baltimore). 2013 Sep;92(5):e1-e9. doi: 10.1097/MD.0b013e3182a71eba.

42.

[Black esophagus].

Hermet A, Lidove O, Grimbert S, Zeller V, Ducroquet F, Ziza JM.

Rev Med Interne. 2014 Jun;35(6):393-5. doi: 10.1016/j.revmed.2013.06.006. Epub 2013 Aug 12. French.

PMID:
23947994
43.

Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study.

Sacre K, Dehoux M, Chauveheid MP, Chauchard M, Lidove O, Roussel R, Papo T.

J Clin Endocrinol Metab. 2013 Aug;98(8):3199-205. doi: 10.1210/jc.2013-1394. Epub 2013 Jun 12.

PMID:
23760625
44.

[Antisynthetase syndrome and lung carcinoma: a fortuitous association?].

Courties A, Lidove O, Maisonobe T, Rigolet A, Hermet A, Girard P, Ziza JM.

Rev Med Interne. 2014 Apr;35(4):271-3. doi: 10.1016/j.revmed.2013.04.012. Epub 2013 May 30. French.

PMID:
23726930
45.

Pulmonary involvement in Fabry disease: overview and perspectives.

Franzen D, Krayenbuehl PA, Lidove O, Aubert JD, Barbey F.

Eur J Intern Med. 2013 Dec;24(8):707-13. doi: 10.1016/j.ejim.2013.05.003. Epub 2013 May 30. Review.

PMID:
23726861
46.

[Fabry disease].

Mirouse A, Lidove O, Mekinian A, Fain O.

Rev Prat. 2013 Mar;63(3):306. French. No abstract available.

PMID:
23687747
47.

[Long-term follow-up of a French cohort of retroperitoneal fibrosis].

Lugosi M, Sacré K, Lidove O, Chauveheid MP, Brihaye B, Laissy JP, Chauchard M, Papo T.

Rev Med Interne. 2013 Oct;34(10):591-9. doi: 10.1016/j.revmed.2013.02.002. Epub 2013 Mar 14. French.

PMID:
23498668
48.

Multidimensional analysis of clinical symptoms in patients with Fabry's disease.

Kaminsky P, Noel E, Jaussaud R, Leguy-Seguin V, Hachulla E, Zenone T, Lavigne C, Marie I, Maillot F, Masseau A, Serratrice C, Lidove O.

Int J Clin Pract. 2013 Feb;67(2):120-7. doi: 10.1111/ijcp.12016.

PMID:
23305474
49.

[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].

Gabignon C, Zeller V, Le Guyader N, Desplaces N, Lidove O, Ziza JM.

Rev Med Interne. 2013 Jan;34(1):39-41. doi: 10.1016/j.revmed.2012.09.006. Epub 2012 Oct 24. French.

PMID:
23102978
50.

[Auditory and vestibular findings in Fabry disease: a study of 25 patients].

Pichon M, Lidove O, Roudaire ML, Barry B, Herman P, Gobert D, Pasqualoni E, Compain C, Chauveheid MP, Papo T.

Rev Med Interne. 2012 Jul;33(7):364-9. doi: 10.1016/j.revmed.2012.01.014. Epub 2012 Feb 24. French.

PMID:
22365473

Supplemental Content

Loading ...
Support Center